Advanced in Generalized Pustular Psoriasis (GPP)

Dr. Bruce E. Katz

Dermatology
Bruce E Katz MD PC
60 E 56th St, 
New York, NY 
Advanced in Generalized Pustular Psoriasis (GPP)
Bruce E Katz MD PC
60 E 56th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bruce Katz is a Dermatologist in New York, New York. Dr. Katz is rated as an Advanced provider by MediFind in the treatment of Generalized Pustular Psoriasis (GPP). His top areas of expertise are Contact Dermatitis, Generalized Pustular Psoriasis (GPP), Comedones, and Jock Itch.

His clinical research consists of co-authoring 28 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

BRUCE E KATZ MD PC
60 E 56th St, New York, NY 10022

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: August 03, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
A Randomized, Double-Blind, Vehicle-Controlled, Sample Size Adaptive Design Study to Evaluate the Safety and Efficacy of Topically Applied EB01 Cream in Healthy Adult Volunteers and Adult Subjects with Moderate to Severe Chronic Allergic Contact Dermatitis
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Drug
Study Drug: EB01 Cream
Study Phase: Phase 2
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
Prospective Clinical Study To Assess The Safety And Efficacy Of The Tempsure Flexsure Applicators For The Treatment Of Abdominal Wrinkles
Prospective Clinical Study To Assess The Safety And Efficacy Of The Tempsure Flexsure Applicators For The Treatment Of Abdominal Wrinkles
Enrollment Status: Terminated
Publish Date: October 07, 2022
Intervention Type: Device
Study Phase: Not Applicable
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Drug
Study Drug: LY3454738
Study Phase: Phase 1
A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
A Randomized, Placebo-Controlled, Dose-Escalation Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
Enrollment Status: Completed
Publish Date: October 05, 2021
Intervention Type: Drug
Study Drug: BMX-010
Study Phase: Phase 2
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (Spinosad) for the Treatment of Scabies
Enrollment Status: Completed
Publish Date: May 21, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
Efficacy and Safety of Deoxycholic Acid Injections for Removal of Adipose Tissue in the Anterior and Posterior Aspect of the Axilla Bra Strap Fat
Efficacy and Safety of Deoxycholic Acid Injections for Removal of Adipose Tissue in the Anterior and Posterior Aspect of the Axilla Bra Strap Fat
Enrollment Status: Completed
Publish Date: April 01, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
Enrollment Status: Completed
Publish Date: October 20, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

28 Total Publications

A Single-Center, Open Label, Study to Evaluate the Effectiveness of Acne Scar Gel (ASG) in Improving Acne Scar Appearance and Reducing Hyperpigmentation in Subjects With Mild-To-Moderate Acne Scars.
A Single-Center, Open Label, Study to Evaluate the Effectiveness of Acne Scar Gel (ASG) in Improving Acne Scar Appearance and Reducing Hyperpigmentation in Subjects With Mild-To-Moderate Acne Scars.
Journal: Journal of cosmetic dermatology
Published: November 17, 2024
Similar Doctors
Elite in Generalized Pustular Psoriasis (GPP)
Dr. Mark G. Lebwohl
Dermatology
Elite in Generalized Pustular Psoriasis (GPP)
Dr. Mark G. Lebwohl
Dermatology
5 E 98th St, 5th Floor Box 1048, 
New York, NY 
 (2.1 miles away)
212-241-5778
Languages Spoken:
English
See accepted insurances

Mark Lebwohl is a Dermatologist in New York, New York. Dr. Lebwohl is rated as an Elite provider by MediFind in the treatment of Generalized Pustular Psoriasis (GPP). His top areas of expertise are Plaque Psoriasis, Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP).

Elite in Generalized Pustular Psoriasis (GPP)
Dr. Alice B. Gottlieb
Dermatology | Rheumatology
Elite in Generalized Pustular Psoriasis (GPP)
Dr. Alice B. Gottlieb
Dermatology | Rheumatology

Icahn School Of Medicine At Mount Sinai

10 Union Sq E, 
New York, NY 
 (2.0 miles away)
212-420-2000
Languages Spoken:
English
See accepted insurances

Alice Gottlieb is a Dermatologist and a Rheumatologist in New York, New York. Dr. Gottlieb is rated as an Elite provider by MediFind in the treatment of Generalized Pustular Psoriasis (GPP). Her top areas of expertise are Psoriasis, Psoriatic Arthritis, Plaque Psoriasis, and Arthritis.

Distinguished in Generalized Pustular Psoriasis (GPP)
Dr. James G. Krueger
Dermatology
Distinguished in Generalized Pustular Psoriasis (GPP)
Dr. James G. Krueger
Dermatology
1230 York Ave, 
New York, NY 
 (0.9 miles away)
212-327-8091
Languages Spoken:
English
See accepted insurances

James Krueger is a Dermatologist in New York, New York. Dr. Krueger is rated as an Elite provider by MediFind in the treatment of Generalized Pustular Psoriasis (GPP). His top areas of expertise are Psoriasis, Hidradenitis Suppurativa, Plaque Psoriasis, Atopic Dermatitis, and Tissue Biopsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Katz's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 36 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile